WOMEN’S MALIGNANCIES BRANCH, CENTER FOR CANCER RESEARCH
NATIONAL CANCER INSTITUTE, NATIONAL INSTITUTES OF HEALTH
DEADLINE: OPEN UNTIL FILLED
The Women’s Malignancies Branch (WMB), Center for Cancer Research (CCR) of the National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Bethesda, MD, invites applications for a clinical/translational tenure track Investigator position in breast or gynecological malignancies. This position is equivalent to an assistant professor position in academia. The successful applicant will establish a vigorous mechanism-based translational and clinical research program investigating the treatment of breast and/or gynecological malignancies. The WMB (https://ccr.cancer.gov/Womens-Malignancies-Branch) is dedicated to improving the outcomes for patients with breast and gynecological malignancies. Specific areas of active research within WMB include: receptor tyrosine kinase signaling, induction of apoptosis in breast cancer cells, prevention of metastasis, the role of NF-kB in ovarian cancer, targeting defects in the DNA damage response pathways in breast and ovarian cancer, and innate and adaptive immune therapy for breast and gynecological malignancies. Applicants with a strong translational/clinical research background in any women’s malignancies that is novel or complementary to the ongoing work are encouraged to apply.
The Center for Cancer Research (CCR) is the intramural research component of the National Cancer Institute (NCI) and the position is located on the NIH Campus in Bethesda. CCR’s enabling infrastructure facilitates clinical studies at the NIH Clinical Center, the world’s largest dedicated clinical research complex; provides extensive opportunities for collaboration; and allows scientists and clinicians to undertake high-risk, high-impact laboratory- and clinic-based investigations. Investigators are supported by a wide array of intellectual and technological and research resources, including animal facilities and dedicated, high quality technology cores in areas such as imaging/microscopy, chemistry/purification, mass spectrometry, flow cytometry, genomics/DNA sequencing, high throughput screening, transgenics and knock out mice, arrays/molecular profiling, and human genetics/bioinformatics and biostatistics. The tenure track Investigator will also have access to clinical resources including funding for clinical trials, and access to nurse practitioners, research nurses, and patient care coordinators. In addition, they will have access to a robust clinical trials infrastructure including data management, training, protocol support office, regulatory support, information systems and technology, and data safety monitoring. The position provides salary and full funding for a laboratory and clinical research program, including office space, budget, support staff and clinical and translational research infrastructures.
For an overview of CCR, please visit http://ccr.cancer.gov/. For more information, contact Lori Holliday, Faculty Recruitment Coordinator, at email@example.com.
A full civil service package of benefits (including health insurance, life insurance, and retirement) is available. Candidates may be U.S. citizens, U.S. permanent residents, or eligible for a visa that will enable work in the United States.
Interested candidates should submit a current curriculum vitae and complete bibliography, and a statement of research and clinical interests (no more than two pages) to https://service.cancer.gov/ccr-careers?id=ccr_careers_public_home. Please include in your curriculum vitae, a description of the mentoring and outreach activities in which you have been involved, especially those involving women and persons from racial/ethnic or other groups that are underrepresented in biomedical research. Finalists will be notified when references are required. Review of applicants will begin on or about May 25, 2020. This search will remain open until a qualified applicant is identified.
This position is subject to a background investigation. The NIH is dedicated to building an inclusive and diverse community in its training and employment programs.
HHS, NIH, and NCI are Equal Opportunity Employers
The NIH and NCI are dedicated to building a diverse community in its training and employment programs and encourages the application and nomination of qualified women, minorities, and individuals with disabilities.
The successful candidate must have an M.D., M.D./Ph. D, or equivalent degree, be board certified or eligible in medical oncology or the equivalent and have a strong record of translational and clinical research accomplishments. Salary will be commensurate with education and experience.
Employer will assist with relocation costs.
Internal Number: 1
About National Cancer Institute, NIH
The Center for Cancer Research (CCR) is the largest division of the NCI intramural research program and comprises nearly 250 basic and clinical research groups located on two campuses outside of Washington, DC.
The CCR is home to an extraordinary group of scientists and clinicians exploring the cutting-edge of cancer and HIV/AIDS research. Our scientists work on a wide spectrum of biological and biomedical problems ranging from visualizing and understanding the structure of individual genes and proteins, developing novel methods for drug discovery, to inventing biomedical devices and technology and creating innovative ways to treat patients in the NIH Clinical Center.
Our scientists enjoy complete intellectual freedom and are expected to creatively and innovatively explore the most important questions in the field of cancer research and treatment. We support projects over a long time horizon allowing our investigators to pursue some of the most difficult, high-risk problems in the field and we are always on the lookout for new challenges and the most pressing problems in modern cancer research.
The success of the CCR is grounded in an exceptionally strong discovery resea...rch program which provides the foundation for the seamless translation of insights into basic cellular and molecular processes to clinical applications and patient care. Examples of our success are the development of ground-breaking immunotherapy approaches, HIV/AIDS test and the creation of human papilloma virus vaccine.
The CCR is a unique place of science where we combine diverse expertise with the freedom to thoroughly pursue the most pressing questions in cancer biology and treatment.
At the CCR, we do cancer research like nobody else!